Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.

Authors
  • 1
  • 1 Institute of Oncology, Polyclinic Hospital, Monza, Italy. , (Italy)
Type
Published Article
Journal
Cancer
1097-0142
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
120
Issue
16
Pages
2457–2463
Identifiers
DOI: 10.1002/cncr.28726
PMID: 24752410
Source
Medline
Keywords
  • Everolimus
  • Neuroendocrine Tumor
  • Octreotide Long-Acting Repeatable

Abstract

Statistics

Seen <100 times